• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

US Oncology Appoints Stephen Smith Vice President/General Manager Research and Personalized Science Services

Posted on: Monday, 25 August 2008, 15:01 CDT

HOUSTON, Aug. 25 /PRNewswire/ -- US Oncology, Inc. today announced the appointment of Stephen Smith as Vice President/General Manager Research and Personalized Science Services. Smith will oversee the US Oncology Research Network, which provides research management services to oncology practices and sites throughout the nationwide US Oncology Network.

The research network allows physicians to accelerate the availability and use of scientific, evidence-based medicine and share best practices. It has played a pivotal role in 24 of the last 30 cancer drugs approved by the FDA and more than 32,000 patients have participated in clinical trials.

Smith joins US Oncology from INC Research, Inc. where he was Senior Vice President, Global Oncology. Prior to INC Research, he worked as CFO of Clinical Pharmacology and Labs for Pharmaceutical Product Development, Inc., a multinational healthcare technology and services firm. Smith served as an officer in the United States Army for five years.

Smith earned a Bachelor of Science degree from the United States Military Academy, a Master of Science degree from the University of Northern Colorado and a Master of Business Administration degree from Syracuse University, Whitman School of Management.

"We are excited to have Stephen as part of our team," said Bruce Broussard, president and chief executive officer of US Oncology. "Our research network is a strategic part of our mission to increase patient access to high-quality cancer care. With Stephen's background and expertise we will further our goal of enhancing patient access to the latest investigational therapies."

"I am proud to be a part of US Oncology. Its continued commitment to such a comprehensive research network and to advancing oncology research in novel ways are important drivers of the innovative services US Oncology supports in all phases of the cancer care delivery system," said Smith.

Smith is based at the company's headquarters in Houston, Texas. About US Oncology, Inc.

US Oncology, headquartered in Houston, works closely with physicians, manufacturers and payers to identify and deliver innovative services that enhance patient access to advanced cancer care. US Oncology supports one of the nation's foremost cancer treatment and research networks accelerating the availability and use of evidence-based medicine and shared best practices.

US Oncology's expertise in supporting every aspect of the cancer care delivery system -- from drug development to treatment and outcomes measurement, enables the company to help increase the efficiency and safety of cancer care. According to the company's last quarterly earnings report, US Oncology is affiliated with 1,247 physicians operating in 472 locations, including 91 radiation oncology facilities in 39 states. For more information, visit the company's Web site, http://www.usoncology.com/.

US Oncology, Inc.

CONTACT: Lisa Henderson of Hill & Knowlton, Inc., +1-813-775-6208,Lisa.Henderson@hillandknowlton.com, for US Oncology, Inc.

Web site: http://www.usoncology.com/

Source: PRNewswire

More News in this Category